NeoGenomics Expands Oncology Testing With Acquisition Of Pathline
NeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MorePosted by Chris Wolski | Apr 8, 2025 | Company News |
NeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MorePosted by Chris Wolski | Apr 4, 2025 | Hematology & Serology |
Babson Diagnostics has expanded its BetterWay blood testing menu to 61 tests, including key thyroid, kidney & cardiovascular health markers.
Read MorePosted by Chris Wolski | Mar 31, 2025 | Centrifuges |
Thermo Fisher Scientific has launched new floor-model centrifuges featuring GreenCool Technology, providing sustainable solutions for labs.
Read MorePosted by Chris Wolski | Mar 11, 2025 | Company News |
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read MorePosted by Chris Wolski | Mar 6, 2025 | Hematology Instrumentation |
Aletta is an autonomous robotic phlebotomy device poised for precise, efficient blood collection centered on patient innovation.
Read More